Lenalidomide 20MG - emergency pharmacy
Ended Awarded
- Contract number
- 36C26126N0208
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $193,101
Award facts
- Contract value 100% obligated
- $193,101.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order contract valued at $193,101.16 to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 20mg to support emergency pharmacy operations. The award, issued on November 13, 2025, is structured as a firm fixed-price delivery order with performance completion targeted for September 30, 2026. Exelan Pharmaceuticals will deliver the medication to a location in Boca Raton, Florida. This contract was awarded without a set-aside designation, allowing the award through unrestricted competitive procurement. The contract operates under the GSA Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which establishes the pricing and terms framework.
Exelan Pharmaceuticals Inc., a Boca Raton-based pharmaceutical company specializing in manufacturing, distribution, and repackaging of generic and branded pharmaceutical products, is well-positioned to fulfill this requirement based on its extensive history serving federal healthcare systems including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The company maintains established relationships with the VA National Acquisition Center through multiple indefinite delivery contracts and holds active registration in SAM.gov through July 30, 2026. Lenalidomide is a specialized immunomodulatory medication used primarily for treating multiple myeloma and certain other blood cancers, making this emergency pharmacy delivery order critical to ensuring VA healthcare facilities maintain adequate supply of this essential therapeutic agent.
Quick answers
Who was awarded contract 36C26126N0208?
36C26126N0208 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on November 13, 2025.
How much is contract 36C26126N0208 worth?
The government has obligated $193,101 on 36C26126N0208.
Is contract 36C26126N0208 an order under another contract?
Yes. 36C26126N0208 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0208 competed?
The extent of competition for 36C26126N0208 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award